Cover Image
市場調查報告書

EpiCast Report:骨關節炎 (OA) - 至2024年的流行病學預測

EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2026

出版商 GlobalData 商品編碼 345646
出版日期 內容資訊 英文 50 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:骨關節炎 (OA) - 至2024年的流行病學預測 EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2026
出版日期: 2017年09月04日 內容資訊: 英文 50 Pages
簡介

在全球主要7個國家(美國、法國、德國、義大利、西班牙、英國、日本),手的骨關節炎 (OA) 確診的患者數,從2014年的150,635,612人預測今後10年達到175,213,683人,1.63%的年度成長率。膝的骨關節炎 (OA) 確診的患者數,從2014年的110,840,501人預測今後10年達到127,929,359人,1.54%的年度成長率。髖關節的骨關節炎 (OA) 確診的患者數,從2014年的61,150,916人預測今後10年達到69,699,696人,1.4%的年度成長率。

本報告提供全球主要7個國家的骨關節炎 (OA) 調查分析、疾病的背景、危險因素和共生病症、全球趨勢、流行病學預測等相關的系統性資訊。

第1章 目錄

第2章 簡介

第3章 流行病學

  • 疾病的背景
  • 危險因素和共生病症
  • 全球趨勢
    • 主要7個國家
  • 預測手法
    • 利用之資訊來源
    • 未利用之資訊來源
    • 預測的前提條件與手法
  • 骨關節炎 (OA) 的流行病學預測
    • 總患者數
    • 髖關節OA的總患者數:性別
    • 確診的患者數
    • 基於膝OA的重病度 (KL等級)
  • 議論
    • 流行病學預測相關考察
    • 分析的限制
    • 分析的優勢

第4章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHCER159-17

Osteoarthritis (OA) is a gradually progressive joint disease that is typically seen in middle-aged to elderly people. According to the American College of Rheumatology (ACR), OA is the most common cause of disability in the elderly. The most commonly affected joints are the knee, hip, hand, and spine. It is characterized by breakdown of the cartilage, bony changes of the joints, deterioration of tendons and ligaments, and various degrees of inflammation of the joint lining.

To forecast the total prevalent cases (radiographic), total prevalent cases (symptomatic), and diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA in the 7MM, GlobalData epidemiologists selected nationally representative, population-based studies that provided these epidemiological data in the 7MM. GlobalData epidemiologists obtained data for the diagnosed prevalent cases (symptomatic) as well as data for the severity segmentation of the diagnosed prevalent cases (symptomatic) from primary market research. In addition, the forecast is supported by robust, country-specific data that was obtained from various authentic sources such as research articles published in peer-reviewed journals.

In the 7MM, GlobalData epidemiologists forecast that the diagnosed prevalent cases (symptomatic) of hand OA will increase from 17,948,101 cases in 2016 to 20,413,591 cases in 2026 at an annual growth rate (AGR) of 1.37%, the diagnosed prevalent cases (symptomatic) of knee OA will increase from 15,235,201 cases in 2016 to 17,641,626 cases in 2026 at an AGR of 1.58%, and the diagnosed prevalent cases (symptomatic) of hip OA will increase from 3,361,141 cases in 2016 to 3,867,480 cases in 2026 at an AGR of 1.51%.

Scope

  • The Osteoarthritis (OA) EpiCast Report provides an overview of the risk factors and global trends of hand OA, knee OA, and hip OA in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • It includes a 10-year epidemiological forecast for the total prevalent cases (radiographic), total prevalent cases (symptomatic), and diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA segmented by age (beginning at 18 years and older) and sex in these markets. The diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA are further segmented by severity using Kellgren-Lawrence (KL) grading into mild (KL = 2), and moderate to severe (KL = 3 to 4).
  • The OA epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The OA EpiCast report will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global OA market.
  • Quantify patient populations in the global OA market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for OA therapeutics in each of the markets covered.
  • Understand magnitude of OA population by disease severity.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 3
  • 1.2 List of Figures 4

2 Osteoarthritis: Executive Summary 5

  • 2.1 Related Reports 8
  • 2.2 Upcoming Reports 8

3 Epidemiology 9

  • 3.1 Disease Background 9
  • 3.2 Risk Factors and Comorbidities 10
  • 3.3 Global and Historical Trends 11
  • 3.4 Forecast Methodology 14
    • 3.4.1 Sources 15
    • 3.4.2 Forecast Assumptions and Methods 20
  • 3.5 Epidemiological Forecast for OA (2016-2026) 26
    • 3.5.1 Total Prevalent Cases (Radiographic) of Hand OA 26
    • 3.5.2 Total Prevalent Cases (Symptomatic) of Hand OA 26
    • 3.5.3 Diagnosed Prevalent Cases (Symptomatic) of Hand OA 27
    • 3.5.4 Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Hand OA 28
    • 3.5.5 Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Hand OA 28
    • 3.5.6 Diagnosed Prevalent Cases (Symptomatic) of Hand OA by Severity 29
    • 3.5.7 Total Prevalent Cases (Radiographic) of Knee OA 30
    • 3.5.8 Total Prevalent Cases (Symptomatic) of Knee OA 31
    • 3.5.9 Diagnosed Prevalent Cases (Symptomatic) of Knee OA 32
    • 3.5.10 Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Knee OA 33
    • 3.5.11 Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Knee OA 34
    • 3.5.12 Diagnosed Prevalent Cases (Symptomatic) of Knee OA by Severity 35
    • 3.5.13 Total Prevalent Cases (Radiographic) of Hip OA 36
    • 3.5.14 Total Prevalent Cases (Symptomatic) of Hip OA 37
    • 3.5.15 Diagnosed Prevalent Cases (Symptomatic) of Hip OA 38
    • 3.5.16 Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Hip OA 39
    • 3.5.17 Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Hip OA 40
    • 3.5.18 Diagnosed Prevalent Cases (Symptomatic) of Hip OA by Severity 41
  • 3.6 Discussion 42
    • 3.6.1 Epidemiological Forecast Insight 42
    • 3.6.2 Limitations of Analysis 42
    • 3.6.3 Strengths of Analysis 43

4 Appendix 44

  • 4.1 Bibliography 44
  • 4.2 High-Prescribing Physician Survey 47
  • 4.3 About the Authors 48
    • 4.3.1 Epidemiologist 48
    • 4.3.2 Reviewers 48
    • 4.3.3 Global Director of Therapy Analysis and Epidemiology 49
    • 4.3.4 Global Head and EVP of Healthcare Operations and Strategy 49
  • 4.4 About GlobalData 50
  • 4.5 Contact Us 50
  • 4.6 Disclaimer 50

List of Tables

1.1 List of Tables

  • Table 1: Risk Factors and Comorbidities for OA 11
  • Table 2: Severity Scoring System for Classifying the Hand, Knee, and Hip OA Using the KL Grading Scale. 15
  • Table 3: 7MM, Total Prevalent Cases (Radiographic) of Hand OA, Both Sexes, Ages ≥18 Years, N, Selected Years 2016-2026 26
  • Table 4: 7MM, Total Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages ≥18 Years, N, Selected Years 2016-2026 27
  • Table 5: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages ≥18 Years, N, Selected Years 2016-2026 27
  • Table 6: 7MM, Total Prevalent Cases (Radiographic) of Knee OA, Both Sexes, Ages ≥18 Years, N, Selected Years 2016-2026 31
  • Table 7: 7MM, Total Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages ≥18 Years, N, Selected Years 2016-2026 31
  • Table 8: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages ≥18 Years, N, Selected Years 2016-2026 32
  • Table 9: 7MM, Total Prevalent Cases (Radiographic) of Hip OA, Both Sexes, Ages ≥18 Years, N, Selected Years 2016-2026 36
  • Table 10: 7MM, Total Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages ≥18 Years, N, Selected Years 2016-2026 37
  • Table 11: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages ≥18 Years, N, Selected Years 2016-2026 38
  • Table 12: High-Prescribing Physicians (Non-KOLs), Surveyed by Country, 2017 47

List of Figures

1.2 List of Figures

  • Figure 1: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages ≥18 Years, 2016 and 2026 6
  • Figure 2: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages ≥18 Years, 2016 and 2026 7
  • Figure 3: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages ≥18 Years, 2016 and 2026 8
  • Figure 4: 7MM, Age-Standardized Diagnosed Prevalence (Symptomatic) (%), Hand OA, Men and Women, Ages ≥18 Years, 2016 12
  • Figure 5: 7MM, Age-Standardized Diagnosed Prevalence (Symptomatic) (%), Knee OA, Men and Women, Ages ≥18 Years, 2016 13
  • Figure 6: 7MM, Age-Standardized Diagnosed Prevalence (Symptomatic) (%), Hip OA, Men and Women, Ages ≥18 Years, 2016 14
  • Figure 7: 7MM, Sources Used to Forecast Total Prevalent Cases (Radiographic), Hand OA 15
  • Figure 8: 7MM, Sources Used to Forecast Total Prevalent Cases (Symptomatic), Hand OA 16
  • Figure 9: 7MM, Sources Used to Forecast Total Prevalent Cases (Radiographic), Knee OA 17
  • Figure 10: 7MM, Sources Used to Forecast Total Prevalent Cases (Symptomatic), Knee OA 18
  • Figure 11: 7MM, Sources Used to Forecast Total Prevalent Cases (Radiographic), Hip OA 19
  • Figure 12: 7MM, Sources Used to Forecast Total Prevalent Cases (Symptomatic), Hip OA 20
  • Figure 13: 7MM, Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages ≥18 Years, N, 2016 28
  • Figure 14: 7MM, Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages ≥18 Years, N, 2016 29
  • Figure 15: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hand OA by Severity, Both Sexes, Ages ≥18 Years, N, 2016 30
  • Figure 16: 7MM, Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages ≥18 Years, N, 2016 33
  • Figure 17: 7MM, Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages ≥18 Years, N, 2016 34
  • Figure 18: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Knee OA by Severity, Both Sexes, Ages ≥18 Years, N, 2016 35
  • Figure 19: 7MM, Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages ≥18 Years, N, 2016 39
  • Figure 20: 7MM, Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages ≥18 Years, N, 2016 40
  • Figure 21: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hip OA by Severity, Both Sexes, Ages ≥18 Years, N, 2016 41
Back to Top